156 related articles for article (PubMed ID: 30402386)
21. Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology.
Aydogdu G; Özekinci S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):10001-10007. PubMed ID: 37916370
[TBL] [Abstract][Full Text] [Related]
22. A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis.
Kurtipek E; Eren Karanis Mİ; Düzgün N; Esme H; Çaycı M
Case Rep Pulmonol; 2015; 2015():962504. PubMed ID: 26451268
[TBL] [Abstract][Full Text] [Related]
23. Malignant pleural mesothelioma diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.
Kang B; Kim MA; Lee BY; Yoon H; Oh DK; Hwang HS; Choi C
Tuberc Respir Dis (Seoul); 2013 Feb; 74(2):74-8. PubMed ID: 23483811
[TBL] [Abstract][Full Text] [Related]
24. A rare case of primary gastric Burkitt's lymphoma associated with malignant pleural mesothelioma.
Spaziani E; Di Filippo AR; Valle G; Spaziani M; Francioni P; Caruso G; Tamagnini GT; Mosciatti E; Picchio M; De Cesare A
Ann Ital Chir; 2023 Mar; 12():. PubMed ID: 36924064
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report.
Yamazoe M; Tomioka H; Kamada T; Kaneko M; Katsuyama E
Respir Med Case Rep; 2019; 26():45-49. PubMed ID: 30533375
[TBL] [Abstract][Full Text] [Related]
26. New-onset malignant pleural effusion after abscess formation of a subcarinal lymph node associated with endobronchial ultrasound-guided transbronchial needle aspiration.
Jang SM; Kim MJ; Cho JS; Lee G; Kim A; Kim JM; Park CH; Park JM; Song BG; Eom JS
Tuberc Respir Dis (Seoul); 2014 Oct; 77(4):188-92. PubMed ID: 25368666
[TBL] [Abstract][Full Text] [Related]
27. Advances in pathological diagnosis of mesothelioma: what pulmonologists should know.
Louw A; Badiei A; Creaney J; Chai MS; Lee YCG
Curr Opin Pulm Med; 2019 Jul; 25(4):354-361. PubMed ID: 31169558
[TBL] [Abstract][Full Text] [Related]
28. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
29. Chylous Ascites Developing Into Bilateral Chylothorax in High-Grade Lymphoma: A Case Report.
Avon JT; Gerrard AJ; Patel BB
Cureus; 2023 Apr; 15(4):e37344. PubMed ID: 37182072
[TBL] [Abstract][Full Text] [Related]
30. Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma.
Kinoshita Y; Hamasaki M; Matsumoto S; Yoshimura M; Sato A; Tsujimura T; Kamei T; Kawahara K; Nabeshima K
Pathol Int; 2020 Sep; 70(9):671-679. PubMed ID: 32542810
[TBL] [Abstract][Full Text] [Related]
31. Chemical Pleurodesis in the Treatment of Recurrent Chylothorax Due to Renal Cell Carcinoma.
Weiss HZ; Knopp BW; Parmar J
Cureus; 2024 Mar; 16(3):e55363. PubMed ID: 38562359
[TBL] [Abstract][Full Text] [Related]
32. Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma.
Şeker NS; Tekin E; Ak G; Metintaş M; Metintaş S; Dündar E
Diagn Cytopathol; 2024 Apr; 52(4):211-216. PubMed ID: 38243885
[TBL] [Abstract][Full Text] [Related]
33. Pleural mesothelioma: When echo-endoscopy (EUS-B-FNA) leads to diagnosis in a minimally invasive way.
Piro R; Fontana M; Livrieri F; Menzella F; Casalini E; Taddei S; De Giorgi F; Facciolongo N
Thorac Cancer; 2021 Mar; 12(6):981-984. PubMed ID: 33533181
[TBL] [Abstract][Full Text] [Related]
34. [A case of malignant pleural mesothelioma with gastrointestinal metastases which were diagnosed by endoscopic biopsy].
Terashita S; Hirano K; Hirai T; Narabayashi T; Hara Y; Mori H; Endo K; Hirabayashi M
Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):133-8. PubMed ID: 19260537
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.
Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Iwasaki A; Okamoto T; Oda Y; Honda H; Nabeshima K
Lung Cancer; 2017 Feb; 104():98-105. PubMed ID: 28213009
[TBL] [Abstract][Full Text] [Related]
36. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
37. Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia.
Yoshimura M; Kinoshita Y; Hamasaki M; Matsumoto S; Hida T; Oda Y; Iwasaki A; Nabeshima K
Lung Cancer; 2019 Apr; 130():187-193. PubMed ID: 30885343
[TBL] [Abstract][Full Text] [Related]
38. A gene-expression-based test can outperform bap1 and
Alì G; Bruno R; Poma AM; Proietti A; Ricci S; Chella A; Melfi F; Ambrogi MC; Lucchi M; Fontanini G
Oncol Lett; 2020 Jan; 19(1):1060-1065. PubMed ID: 31897219
[TBL] [Abstract][Full Text] [Related]
39. Chylothorax with Transudate: An Unusual Presentation of Tuberculosis.
Zamora-López MA; Farias-Navarro IC; Rendon-Ramirez EJ
Eur J Case Rep Intern Med; 2020; 7(8):001645. PubMed ID: 32789131
[TBL] [Abstract][Full Text] [Related]
40. Morphological difference between pleural mesothelioma cells in effusion smears with either BAP1 loss or 9p21 homozygous deletion and reactive mesothelial cells without the gene alterations.
Matsumoto S; Hamasaki M; Kinoshita Y; Kamei T; Kawahara K; Nabeshima K
Pathol Int; 2019 Nov; 69(11):637-645. PubMed ID: 31580004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
